Literature DB >> 31659435

Preoperative total cholesterol-lymphocyte score as a novel immunonutritional predictor of survival in gastric cancer.

Daiki Matsubara1, Katsutoshi Shoda1, Takeshi Kubota2, Toshiyuki Kosuga1, Hirotaka Konishi1, Atsushi Shiozaki1, Hitoshi Fujiwara1, Kazuma Okamoto1, Michihiro Kudou1, Tomohiro Arita1, Ryo Morimura1, Yasutoshi Murayama1, Hisashi Ikoma1, Yoshiaki Kuriu1, Masayoshi Nakanishi1, Eigo Otsuji1.   

Abstract

PURPOSE: Immunonutritional status is a known prognostic correlate in the context of gastric cancer (GC). In the present study, we investigated the prognostic relevance of a lipid profile-based immunonutritional score in patients with GC.
METHODS: Data pertaining to 224 patients with stage II and III GC who underwent curative gastrectomy were retrospectively analyzed. The total cholesterol-lymphocyte score (TL score) was defined as follows: patients with both low total cholesterol (TC) and total lymphocyte count were allocated a score of 2; patients with only one or none of these biochemical abnormalities were allocated a score of 1 or 0, respectively.
RESULTS: Among the serum lipid indices, low TC was the strongest predictor of cancer-specific survival (CSS; p = 0.001). On multivariate analysis, both low prognostic nutritional index (PNI) (p < 0.001) and high TL score (p = 0.003) were independent prognostic factors. PNI was significantly associated with peritoneal recurrence (p = 0.047), while TL score was significantly associated with locoregional and distant metastasis (p = 0.004 and p = 0.003, respectively).
CONCLUSIONS: TL score may facilitate risk stratification of patients based on CSS. TL score plus PNI may help predict the recurrence pattern in patients with stage II and III GC.

Entities:  

Keywords:  Cholesterol; Gastric cancer; Immunonutritional score; Lipid profile; Lymphocyte count

Mesh:

Substances:

Year:  2019        PMID: 31659435     DOI: 10.1007/s00423-019-01824-8

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  39 in total

1.  Japanese classification of gastric carcinoma: 3rd English edition.

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

2.  Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection.

Authors:  Daisuke Kuroda; Hiroshi Sawayama; Junji Kurashige; Masaaki Iwatsuki; Tsugio Eto; Ryuma Tokunaga; Yuki Kitano; Kensuke Yamamura; Mayuko Ouchi; Kenichi Nakamura; Yoshifumi Baba; Yasuo Sakamoto; Yoichi Yamashita; Naoya Yoshida; Akira Chikamoto; Hideo Baba
Journal:  Gastric Cancer       Date:  2017-06-27       Impact factor: 7.370

3.  Influence of prognostic nutritional index and tumor markers on survival in gastric cancer surgery patients.

Authors:  Hiroaki Saito; Yusuke Kono; Yuki Murakami; Hirohiko Kuroda; Tomoyuki Matsunaga; Yoji Fukumoto; Tomohiro Osaki
Journal:  Langenbecks Arch Surg       Date:  2017-03-15       Impact factor: 3.445

4.  The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer.

Authors:  Xing Li; Hailin Tang; Jin Wang; Xinhua Xie; Peng Liu; Yanan Kong; Feng Ye; Zeyu Shuang; Zeming Xie; Xiaoming Xie
Journal:  Breast       Date:  2016-12-08       Impact factor: 4.380

5.  Preoperative immunonutrition suppresses perioperative inflammatory response in patients with major abdominal surgery-a randomized controlled pilot study.

Authors:  Urs Giger; Markus Büchler; Jian Farhadi; Dieter Berger; Jürg Hüsler; Heinz Schneider; Stephan Krähenbühl; Lukas Krähenbühl
Journal:  Ann Surg Oncol       Date:  2007-07-15       Impact factor: 5.344

6.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

7.  Lymphopenia predicts poor prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Ji-Feng Feng; Jin-Shi Liu; Ying Huang
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

8.  Preoperative serum lipids as prognostic predictors in esophageal squamous cell carcinoma patients with esophagectomy.

Authors:  Pengxiang Chen; Lihui Han; Cong Wang; Yibin Jia; Qingxu Song; Jianbo Wang; Shanghui Guan; Bingxu Tan; Bowen Liu; Wenqiao Jia; Jianfeng Cui; Wei Zhou; Yufeng Cheng
Journal:  Oncotarget       Date:  2017-06-20

9.  Serum low-density lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC).

Authors:  Ting Zhou; Jianhua Zhan; Wenfeng Fang; Yuanyuan Zhao; Yunpeng Yang; Xue Hou; Zhonghan Zhang; Xiaobo He; Yaxiong Zhang; Yan Huang; Li Zhang
Journal:  BMC Cancer       Date:  2017-04-14       Impact factor: 4.430

10.  Comparison of the prognostic impact and combination of preoperative inflammation-based and/or nutritional markers in patients with stage II gastric cancer.

Authors:  Takahiro Toyokawa; Kazuya Muguruma; Tatsuro Tamura; Katsunobu Sakurai; Ryosuke Amano; Naoshi Kubo; Hiroaki Tanaka; Masakazu Yashiro; Kosei Hirakawa; Masaichi Ohira
Journal:  Oncotarget       Date:  2018-06-29
View more
  2 in total

1.  Geriatric Nutritional Risk Index Predicts Poor Prognosis of Patients After Curative Surgery for Gastric Cancer.

Authors:  Hirotaka Furuke; Daiki Matsubara; Takeshi Kubota; Jun Kiuchi; Hidemasa Kubo; Takuma Ohashi; Hiroki Shimizu; Tomohiro Arita; Yusuke Yamamoto; Hirotaka Konishi; Ryo Morimura; Atsushi Shiozaki; Yoshiaki Kuriu; Hisashi Ikoma; Hitoshi Fujiwara; Kazuma Okamoto; Eigo Otsuji
Journal:  Cancer Diagn Progn       Date:  2021-05-03

Review 2.  Gastric and gastroesophageal junction cancer: Risk factors and prophylactic treatments for prevention of peritoneal recurrence after curative intent surgery.

Authors:  Biying Huang; Ioannis Rouvelas; Magnus Nilsson
Journal:  Ann Gastroenterol Surg       Date:  2022-03-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.